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Abstract 
Background: The composition of the cerebrospinal fluid (CSF) is not homogeneous, and concentrations of proteins 
from different origins diverge among ventricular, cisternal and lumbar CSF fractions. Concentrations of blood-derived 
proteins increase and of brain-derived proteins decrease from ventricular to lumbar fractions. We studied whether the 
origin of the CSF portion analysed may affect results in CSF analysis for dementia.
Methods: In 16 geriatric patients with suspected normal pressure hydrocephalus [age 82.5 (76/87) years; median 
(25th/75th percentile)] a lumbar spinal tap of 40 ml was performed. The CSF was sequentially collected in 8 fractions 
of 5 ml with the 1st fraction corresponding to lumbar CSF, the 8th to cisterna magna-near CSF. Fractions were ana-
lysed for total protein, albumin, Tau protein (Tau), phosphorylated Tau (pTau), Amyloid beta 1–42 (Aβ1–42), Amyloid 
beta 1–40 (Aβ1–40), and the Aβ1–42/Aβ1–40 ratio.
Results: The concentrations of total protein and albumin increased from cisternal to lumbar fractions due to dif-
fusion-related accumulation from blood to CSF with significantly higher concentrations in fraction 1 compared to 
fraction 8. The concentrations of Tau showed a non-significant trend towards decreased values in lumbar samples, 
and pTau was slightly, but significantly decreased in the lumbar fraction 1 [26.5 (22.5/35.0) pg/ml] compared to the 
cistern-near fraction 8 [27.0 (24.2/36.3) pg/ml] (p = 0.02, Wilcoxon signed rank test). Aβ1-42, Aβ1-40, and the Aβ1-42/
Aβ1-40 ratio remained almost constant.
Conclusions: According to the flow-related diverging dynamics of blood-derived and brain-derived proteins in CSF, 
the concentrations of Tau and pTau tended to be lower in lumbar compared to cisternal CSF fractions after a spinal 
tap of 40 ml. The differences reached statistical significance for pTau only. The small differences will not affect clinical 
interpretation of markers of dementia in the vast majority of cases.
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Background
Normal pressure hydrocephalus (NPH) is characterized 
clinically by the triad of gait disturbance, bladder incon-
tinence, and later dementia. Cerebral imaging shows 
ventricular dilation, whereas the subarachnoid space on 
both sides of the superior sagittal sinus is comparatively 
small [1]. Unlike in acute or subacute obstructive hydro-
cephalus, response to surgical shunt treatment in NPH is 
difficult to predict [2]. At autopsy, many of these patients 
display pathological findings suggesting neurodegenerative 
disease. Morphological findings of Alzheimer’s dementia 
(AD) were detected in 30 to 75 % of patients with clinically 
diagnosed NPH where a biopsy was available suggesting a 
large subgroup of patients with overlapping clinical features 
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of both AD and NPH [1–5]. A spinal tap of 40 ml is a rela-
tively insensitive, minimally-invasive procedure to assess 
which patients may benefit from ventriculoperitoneal 
shunting.
Many compounds do not distribute homogeneously in 
the CSF spaces, but have ventriculo-lumbar or lumbo-
ventricular gradients. Compounds originating in the 
brain (e.g., Tau protein, neuron-specific enolase, S-100 
protein) generally have higher ventricular than lumbar 
CSF concentrations, whereas compounds originating 
from the meninges (e.g., β-trace protein and cystatin C) 
have higher lumbar than ventricular levels, and the con-
centrations of blood-derived proteins such as albumin 
increase from the ventricular to the lumbar CSF space 
[6–8]. In pathological conditions with decreased CSF 
flow or in central nervous system bacterial infections, 
where the CSF spaces can be, in part, obstructed by pus, 
the distribution of leukocytes and proteins can be par-
ticularly inhomogeneous, whereas the small molecule 
lactate is distributed homogeneously even in this condi-
tion [9]. Amyloid beta 1–42 (Aβ1–42, molecular mass 
4514 Da), Amyloid beta 1–40 (Aβ1–40, molecular mass 
4330  Da), Tau protein (Tau) and Tau protein phospho-
rylated at position 181 (pTau) (molecular mass 36800–
45900  Da) are proteins originating from the brain and 
the myelon which help to discriminate AD from other 
types of dementia [4]. In a usual diagnostic lumbar punc-
ture, approximately 5–10 ml of CSF is removed, and CSF 
analysis is performed on this fraction. Here, we collected 
40 ml of CSF in fractions of 5 ml, to assess whether the 
markers are evenly distributed in these CSF fractions, or 
whether a ventriculo-lumbar concentration gradient can 
be also detected between the cistern-near and lumbar 
fractions, a situation which may affect the interpretation 
of these markers in the differential diagnosis of dementia.
Methods
A diagnostic or therapeutic lumbar spinal tap of 40  ml 
was performed on 16 patients with suspected or docu-
mented normal pressure hydrocephalus [11 women, 5 
men, age 82.5 (76/87) years; median (25th/75th percen-
tile)]. All patients suffered from cognitive impairment. In 
15 of the 16 patients an abnormal gait, and in 10 patients 
bladder incontinence were documented. All patients 
had an abnormal cranial computer tomography (CCT) 
scan with wide ventricles compared to the width of the 
sulci. Moreover, 14 patients had crowding of the gyri at 
the vertex with small sulci close to the superior sagittal 
sinus, and 14 patients had a corpus callosum angle below 
90°. Four patients (including a patient who received three 
lumbar punctures) clearly improved after the spinal taps, 
and in three patients a small clinically non-significant 
improvement of either gait or cognition were noted. 
None of the patients studied had a ventriculoperitoneal 
shunt or external ventriculostomy. The treating physi-
cians recommended ventriculoperitoneal shunting to the 
4 patients with clear clinical improvement after the spinal 
tap. Because of their advanced age, these patients and/or 
their relatives refused surgery, as they feared the risks.
The CSF was sequentially collected in eight fractions of 
5 ml in polypropylene tubes and was transported to the 
laboratory within 1  h for analysis. One set of CSF frac-
tions was available from 15 patients. Three sets of CSF 
fractions were available from one patient with docu-
mented normal pressure hydrocephalus, who underwent 
repeated lumbar punctures as part of his therapy.
Albumin, immunoglobulins IgG, IgA and IgM were 
determined by nephelometry, and CSF leukocytes were 
counted manually in a Fuchs-Rosenthal chamber. Albu-
min and immunoglobulin CSF/serum quotients (IgG, 
IgA, IgM) were calculated in fraction 1. The CSF protein 
contents were measured by nephelometry using Gesa-
mteiweiß UC Standard FS (DiaSys Diagnostic Systems, 
Holzheim, Germany). After centrifugation at 200×g, 
aliquots of each fraction were stored at −80  °C for the 
determination of markers of dementia, protein and albu-
min concentrations.
Tau protein (Tau), tau protein phosphorylated at thre-
onine 181 (pTau), Amyloid beta 1–42 and Amyloid beta 
1–40 (Aβ1–42 and Aβ1–40) were measured by com-
mercially-available immunoassays (Innotest hTAU Ag, 
Innotest PHOSPHO-TAU 181P, Innotest β-AMYLOID 
1–42, Fujirebio, Gent, Belgium; Amyloid-beta 1–40 CSF 
ELISA, IBL, Hamburg, Germany), and the Aβ1–42/Aβ1–
40 ratio was calculated. The raw data were uploaded as 
Additional file 1 on Aug 6th, 2016.
Correlation of measured values between fraction 1 
and fraction 8 of each individual patient was assessed 
by Spearman’s rank correlation coefficient rS. The con-
centrations of the compounds measured in fractions 1 
and 8 were compared by the two-tailed non-parametric 
paired Wilcoxon signed rank test using Gaph Pad Prism 
software, as most parameters were not normally distrib-
uted. P values <0.05 were considered statistically signifi-
cant. The study was approved by the Ethics Committee 
of the Medical Faculty of the Georg-August University 
Göttingen, Germany, and each participant gave written 
informed consent to participate in this study.
Results
The CSF leukocyte counts were normal in all patients 
studied, and the Reiber–Felgenhauer diagrams of albu-
min- and immunoglobulin-CSF/serum quotients (IgG, 
IgA, IgM) indicated absence of inflammation in all 
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patients studied. Three patients had an elevated CSF-
serum albumin ratio (10.2, 14.9 and 15.4 × 10−3) probably 
because of an impaired circulation of the CSF in the spi-
nal canal: one of these patients had prior surgery because 
of stenosis of the lumbar spinal canal, one had a history 
of two fractures of lumbar vertebrae, and one suffered 
from lower back pain with hardening of muscles, sug-
gesting degenerative spine disease. The concentrations 
of the parameters measured in fractions 1 and 8 of each 
individual patient were strongly correlated (rS  ≥  0.81, 
p  <  0.0001). The CSF protein contents were lower in 
the cistern-near fraction 8 than in the lumbar fraction 1 
(p < 0.0001, Wilcoxon signed rank test) (Table 1). Albu-
min as a strictly blood-derived protein showed a rostro-
caudal increase of concentration with significantly lower 
values in the cistern-near fraction 8 than in the lumbar 
fraction 1 (p < 0.0001, Wilcoxon signed rank test).
pTau concentrations in the CSF fraction 8 were slightly, 
but significantly higher than in lumbar CSF (medians 27.0 
versus 26.5 pg/ml, p = 0.02) indicating a small decrease 
of pTau from cisternal to lumbar CSF. Tau concentrations 
also were slightly higher in CSF fraction 8 than in lum-
bar CSF, the difference, however, failed to reach statistical 
significance (Table 1). No differences among fractions 8 
and 1 were found for Aβ1–40, Aβ1–42 and the Aβ1–42/
Aβ1–40 ratio. Only one patient had an elevated CSF Tau 
concentration (893 pg/ml in fraction 1 and 884 pg/ml in 
fraction 8). No patient had an elevated pTau (>61 pg/ml) 
or an abnormal CSF Aβ1–42 concentration (<450 pg/ml).
In the patient with 3 consecutive spinal taps in 
11  months the intra-individual variation of the deter-
mined markers of neurodegenerative disease was low. 
Concentrations of Tau in the lumbar fraction 1 ranged 
from 148 to 176 pg/ml, of pTau from 25.5 to 28.0 pg/ml, 
of Aβ1–42 from 859 to 933 pg/ml, of Aβ1–40 from 8815 
to 9731  pg/ml, and the Aβ1–42/Aβ1–40 ratio ranged 
from 0.088 to 0.106.
Discussion
The total volume of CSF in adults is approximately 
140 ml with a wide variation dependent on age, and vol-
ume of the brain and medulla spinalis in relation to the 
size of the cranial cavity and the spinal canal. The volume 
of the spinal subarachnoid fluid is 30–80 ml [6, 10], i.e., 
the first 5 ml fraction in our study represents lumbar CSF, 
whereas the 8th 5 ml fraction contains a large proportion 
of CSF from regions close to the cisterna magna and cis-
terna pontis.
In agreement with flow-related diverging dynamics of 
blood-derived and brain-derived proteins in CSF [7], we 
found an increase in the blood-derived protein albumin 
from cisternal to lumbar fractions and correspondingly 
an increase in total protein. In the analysis of markers of 
degenerative disorders, we found a small, statistically sig-
nificant decrease in pTau from cisternal to lumbar frac-
tions and a similar, yet not significant, decrease of Tau in 
fraction 1 (lumbar CSF) compared to fraction 8 (predomi-
nantly cisternal CSF), i.e. median pTau and Tau concen-
trations were higher in the cistern-near than in the lumbar 
CSF. In the patient receiving three spinal taps, the intra-
individual variance between the different sampling points 
of pTau and Tau in lumbar CSF was higher (25.5–28.0 and 
148–176 pg/ml, respectively) than the difference at group 
level between fraction 8 and 1 (27.0 versus 26.5  pg/ml 
and 210 versus 188  pg/ml). It has to be considered that 
these samples from one individual patient were drawn in 
an interval of 11  months. In two of these three samples 
from this patient, the pTau and Tau concentrations in 
cistern-near were higher than in lumbar CSF supporting 
our concept of a small cisterno-lumbar gradient of pTau 
and Tau. Similar rostro-caudal gradients have been found 
for α-synuclein and NSE in 5 patients with NPH [8]. In 
contrast to the small cisterno-lumbar concentration dif-
ferences for pTau and Tau found in fractions 8 and 1 in 
the present study, the ventriculo-lumbar concentration 
Table 1 Markers of dementia and protein concentrations in lumbar (fraction 1) and cistern-near cerebrospinal fluid (frac-
tion 8) (n = 16 pairs of samples)






Tau (pg/ml) PTau (pg/ml) Aβ1–42 (pg/ml) Aβ1–40 (pg/ml) Aβ1–42/
Aβ1–40
Fraction 1 8 1 8 1 8 1 8 1 8 1 8 1 8
Median 433 353 253 202 188 210 26.5 27.0 985 955 12567 12576 0.077 0.075
25th percentile 309 240 177 138 145 151 22.5 24.2 765 783 11215 11045 0.065 0.065
75th percentile 513 427 288 234 280 265 35.0 36.3 1279 1191 15691 15465 0.088 0.087
Correlation between 
fraction 1 and 8 (rS)
0.95* 0.91* 0.94* 0.98* 0.97* 0.93* 0.81*
Fraction 1 versus 8,
p value; Wilcoxon 
signed rank test
<0.0001 <0.0001 NS 0.02 NS NS NS
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ratios in NPH patients for Tau and pTau were previously 
found to be approximately five and twofold, respectively 
[11–13]. The existence of a ventriculo-lumbar Tau and 
pTau gradient was shown to depend on the diagnosis: 
it was large in NPH, but apparently absent in post-trau-
matic hydrocephalus [11]. The ventriculo-lumbar gradi-
ent observed previously and the cisterno-lumbar gradient 
observed by us suggests that Tau and pTau are mainly 
brain-derived, and that the fluids entering the spinal CSF 
from blood (interstitial fluid of the medulla spinalis and 
of the meninges) contain lower Tau and pTau concentra-
tions than the interstitial fluid of the brain. This compares 
well with immunohistochemical findings demonstrating 
that in the spinal cord and the peripheral nervous sys-
tem Tau immuno-reactivity is less abundant than in the 
brain [14]. Conversely, in previous studies lumbar Aβ1–40 
and Aβ1–42 concentrations were slightly higher than the 
respective ventricular levels [12, 13]. In the present study, 
no clear gradients of Aβ1–40 and Aβ1–42 concentrations 
were observed, possibly as a consequence of their lower 
molecular mass compared to Tau proteins facilitating a 
more homogeneous distribution [9].
The median total protein content and the albumin 
concentrations were 1.23- and 1.25-fold higher, respec-
tively, in fraction 1 than in fraction 8. This reflects a rel-
evant influx of proteins from non-neuronal sources into 
the CSF in the spinal canal. In a previous study of 21 
patients with NPH, 10 fractions of approximately 3  ml 
were drawn, and the albumin concentrations were 1.5-
fold higher in fraction 1 than in fraction 10 [15]. Since the 
CSF flow dynamics are altered in NPH, these gradients of 
1.25 or 1.5 in a spinal tap of 30–40 ml may not represent 
the gradients in healthy persons or patients with other 
diseases. Because high volumes of CSF can only be drawn 
with a clear clinical indication, it would be very difficult 
to obtain similar data in healthy adults or patients with 
other diseases. Patients with other forms of dementia, in 
particular those with Alzheimer`s disease, also develop 
brain atrophy (hydrocephalus ex vacuo) altering the 
dynamics of CSF flow, and many elderly patients suf-
fer from degenerative spine disease impairing the circu-
lation of the CSF in the spinal canal. For these reasons, 
we suggest that the cisterno-lumbar gradients of protein, 
albumin and markers of neurodegenerative diseases in 
the spinal canal may be similar in elderly patients with 
dementia irrespective of its cause. Lumbar (fraction 1) 
and cisternal (fraction 8) Tau, pTau, Aβ1–40 and Aβ1–
42 concentrations and the Aβ1–40/Aβ1–42 ratios were 
closely correlated (Table 1) suggesting that these concen-
trations strongly depend on each other as a consequence 
of CSF bulk flow and diffusion.
Conclusions
The rostro-caudal gradient of pTau and Tau in this and 
other studies on NPH suggests that both proteins are 
mainly brain-derived. This gradient, however, may not be 
present in all diseases. The differences between pTau and 
Tau concentrations in lumbar and cistern-near CSF were 
small, and the Aβ1–42 and Aβ1–40 concentrations and 
Aβ1–40/Aβ1–42 ratios in lumbar and cistern-near CSF 
were almost equal. Therefore, all fractions of CSF after a 
spinal tap of 40 ml appear to be equally suitable for the 
assessment of markers of dementia in CSF.
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